A federal judge in Massachusetts on Thursday dismissed a defamation lawsuit against Bill Cosby by an actress who claimed he raped her, ruling that the comedian acted within his rights when he proclaimed himself innocent of the crime. The civil lawsuit is one of a slew of cases brought against the actor, best known for playing the father in the 1980s television hit "The Cosby Show," by about 50 women who say he sexually assaulted them, often after plying them with drugs and alcohol, in a series of alleged attacks dating back decades. The vast bulk of the claims are too old to be the subject of a criminal prosecution, though Cosby is also awaiting trial in Pennsylvania on charges he sexually assaulted a former basketball coach at his alma mater, Temple University.
By Susan Cornwell WASHINGTON (Reuters) - U.S. President Donald Trump's choice to lead an important health agency said on Thursday that the way pharmaceutical companies classify products as generic or branded needs to be reviewed in order to help hold down government spending, as she cited Mylan NV's EpiPen emergency allergy treatment. Seema Verma, Trump's nominee to lead the Centers for Medicare and Medicaid Services (CMS), did not answer questions about whether the U.S. government should negotiate with pharmaceutical companies over drug prices. "I think what happened with ... the EpiPen issue is very disturbing," Verma said at her confirmation hearing before the Senate Finance Committee.
No comments:
Post a Comment